US Stock MarketDetailed Quotes

Benitec Biopharma (BNTC)

Watchlist
  • 11.650
  • -0.190-1.60%
Close May 13 16:00 ET
  • 11.650
  • 0.0000.00%
Post 18:51 ET
400.23MMarket Cap-10.79P/E (TTM)

Benitec Biopharma (BNTC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
50.98%-3.78M
26.93%-3.35M
-21.57%-23.59M
-149.41%-8.21M
49.97%-3.09M
-43.58%-7.7M
-0.20%-4.59M
-7.72%-19.4M
19.58%-3.29M
-53.09%-6.17M
Net income from continuing operations
-23.92%-11.84M
-77.21%-8.97M
-74.32%-37.92M
-242.10%-16.15M
-67.31%-7.16M
-40.51%-9.55M
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
Depreciation and amortization
48.15%120K
29.67%118K
15.45%396K
29.67%118K
17.78%106K
1.25%81K
10.98%91K
-9.97%343K
8.33%91K
-3.23%90K
Other non cash items
----
----
---764K
--0
--0
----
----
----
----
----
Change In working capital
192.74%562K
696.23%316K
-332.45%-2.73M
-738.89%-5.64M
264.21%3.57M
-148.13%-606K
-104.40%-53K
64.43%1.17M
147.75%882K
-1,185.50%-2.17M
-Change in receivables
--123K
-86.73%30K
211.93%197K
83.52%-29K
--0
--0
--226K
-252.00%-176K
---176K
--0
-Change in prepaid assets
-400.00%-195K
56.00%156K
-117.21%-111K
36.45%-258K
-108.78%-18K
-52.55%65K
-85.90%100K
255.80%645K
-1.50%-406K
151.00%205K
-Change in payables and accrued expense
220.60%720K
152.94%162K
-350.92%-2.46M
-441.53%-5.24M
259.64%3.68M
-150.13%-597K
-154.45%-306K
-31.47%980K
87.07%1.53M
-446.92%-2.31M
-Change in other current liabilities
-16.22%-86K
56.16%-32K
-29.45%-356K
-55.71%-109K
-44.93%-100K
-7.25%-74K
-8.96%-73K
-9.13%-275K
-9.38%-70K
-9.52%-69K
Cash from discontinued investing activities
Operating cash flow
50.98%-3.78M
26.93%-3.35M
-21.57%-23.59M
-149.41%-8.21M
49.97%-3.09M
-43.58%-7.7M
-0.20%-4.59M
-7.72%-19.4M
19.58%-3.29M
-53.09%-6.17M
Investing cash flow
Cash flow from continuing investing activities
89.94%-18K
0
96.65%-6K
-17,800.00%-179K
0
-179K
Net PPE purchase and sale
----
----
89.94%-18K
--0
96.65%-6K
----
----
-17,800.00%-179K
--0
---179K
Cash from discontinued investing activities
Investing cash flow
8.33%-11K
--0
89.94%-18K
--0
96.65%-6K
---12K
--0
-17,800.00%-179K
--0
---179K
Financing cash flow
Cash flow from continuing financing activities
449.69%98.23M
0
3.61%70.49M
-93.65%2.54M
28.41M
45,720.51%17.87M
-22.43%21.66M
324.78%68.03M
40.07M
0
Net common stock issuance
----
----
-57.03%30.46M
-100.00%1K
-23,156.41%-9.07M
45,730.77%17.87M
-29.88%21.66M
296.35%70.88M
--40M
---39K
Proceeds from stock option exercised by employees
----
--0
1,293.81%42.34M
-12.80%2.62M
----
----
--21.66M
--3.04M
--3M
----
Net other financing activities
----
----
60.64%-2.32M
97.54%-72K
---2.25M
----
----
-215.25%-5.89M
---2.93M
--0
Cash from discontinued financing activities
Financing cash flow
449.69%98.23M
--0
3.61%70.49M
-93.65%2.54M
--28.41M
45,720.51%17.87M
-22.43%21.66M
324.78%68.03M
--40.07M
--0
Net cash flow
Beginning cash position
39.30%94.59M
92.14%97.86M
1,945.34%50.93M
632.17%103.65M
284.27%78.35M
162.41%67.91M
1,945.34%50.93M
-38.91%2.49M
115.63%14.16M
93.23%20.39M
Current changes in cash
830.01%94.44M
-119.63%-3.35M
-3.24%46.88M
-115.41%-5.67M
498.96%25.32M
290.67%10.16M
-26.87%17.07M
2,524.77%48.45M
997.90%36.78M
-57.53%-6.35M
Effect of exchange rate changes
-146.32%-132K
190.53%86K
712.50%49K
-2,300.00%-120K
-118.26%-21K
274.85%285K
-311.11%-95K
-101.94%-8K
-123.81%-5K
167.44%115K
End cash Position
141.12%188.9M
39.30%94.59M
92.14%97.86M
92.14%97.86M
632.17%103.65M
284.27%78.35M
162.41%67.91M
1,945.34%50.93M
1,945.34%50.93M
115.63%14.16M
Free cash flow
50.91%-3.79M
26.93%-3.35M
-20.55%-23.61M
-149.41%-8.21M
51.28%-3.09M
-43.80%-7.72M
-0.20%-4.59M
-8.71%-19.58M
19.60%-3.29M
-57.53%-6.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 50.98%-3.78M26.93%-3.35M-21.57%-23.59M-149.41%-8.21M49.97%-3.09M-43.58%-7.7M-0.20%-4.59M-7.72%-19.4M19.58%-3.29M-53.09%-6.17M
Net income from continuing operations -23.92%-11.84M-77.21%-8.97M-74.32%-37.92M-242.10%-16.15M-67.31%-7.16M-40.51%-9.55M15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M
Depreciation and amortization 48.15%120K29.67%118K15.45%396K29.67%118K17.78%106K1.25%81K10.98%91K-9.97%343K8.33%91K-3.23%90K
Other non cash items -----------764K--0--0--------------------
Change In working capital 192.74%562K696.23%316K-332.45%-2.73M-738.89%-5.64M264.21%3.57M-148.13%-606K-104.40%-53K64.43%1.17M147.75%882K-1,185.50%-2.17M
-Change in receivables --123K-86.73%30K211.93%197K83.52%-29K--0--0--226K-252.00%-176K---176K--0
-Change in prepaid assets -400.00%-195K56.00%156K-117.21%-111K36.45%-258K-108.78%-18K-52.55%65K-85.90%100K255.80%645K-1.50%-406K151.00%205K
-Change in payables and accrued expense 220.60%720K152.94%162K-350.92%-2.46M-441.53%-5.24M259.64%3.68M-150.13%-597K-154.45%-306K-31.47%980K87.07%1.53M-446.92%-2.31M
-Change in other current liabilities -16.22%-86K56.16%-32K-29.45%-356K-55.71%-109K-44.93%-100K-7.25%-74K-8.96%-73K-9.13%-275K-9.38%-70K-9.52%-69K
Cash from discontinued investing activities
Operating cash flow 50.98%-3.78M26.93%-3.35M-21.57%-23.59M-149.41%-8.21M49.97%-3.09M-43.58%-7.7M-0.20%-4.59M-7.72%-19.4M19.58%-3.29M-53.09%-6.17M
Investing cash flow
Cash flow from continuing investing activities 89.94%-18K096.65%-6K-17,800.00%-179K0-179K
Net PPE purchase and sale --------89.94%-18K--096.65%-6K---------17,800.00%-179K--0---179K
Cash from discontinued investing activities
Investing cash flow 8.33%-11K--089.94%-18K--096.65%-6K---12K--0-17,800.00%-179K--0---179K
Financing cash flow
Cash flow from continuing financing activities 449.69%98.23M03.61%70.49M-93.65%2.54M28.41M45,720.51%17.87M-22.43%21.66M324.78%68.03M40.07M0
Net common stock issuance ---------57.03%30.46M-100.00%1K-23,156.41%-9.07M45,730.77%17.87M-29.88%21.66M296.35%70.88M--40M---39K
Proceeds from stock option exercised by employees ------01,293.81%42.34M-12.80%2.62M----------21.66M--3.04M--3M----
Net other financing activities --------60.64%-2.32M97.54%-72K---2.25M---------215.25%-5.89M---2.93M--0
Cash from discontinued financing activities
Financing cash flow 449.69%98.23M--03.61%70.49M-93.65%2.54M--28.41M45,720.51%17.87M-22.43%21.66M324.78%68.03M--40.07M--0
Net cash flow
Beginning cash position 39.30%94.59M92.14%97.86M1,945.34%50.93M632.17%103.65M284.27%78.35M162.41%67.91M1,945.34%50.93M-38.91%2.49M115.63%14.16M93.23%20.39M
Current changes in cash 830.01%94.44M-119.63%-3.35M-3.24%46.88M-115.41%-5.67M498.96%25.32M290.67%10.16M-26.87%17.07M2,524.77%48.45M997.90%36.78M-57.53%-6.35M
Effect of exchange rate changes -146.32%-132K190.53%86K712.50%49K-2,300.00%-120K-118.26%-21K274.85%285K-311.11%-95K-101.94%-8K-123.81%-5K167.44%115K
End cash Position 141.12%188.9M39.30%94.59M92.14%97.86M92.14%97.86M632.17%103.65M284.27%78.35M162.41%67.91M1,945.34%50.93M1,945.34%50.93M115.63%14.16M
Free cash flow 50.91%-3.79M26.93%-3.35M-20.55%-23.61M-149.41%-8.21M51.28%-3.09M-43.80%-7.72M-0.20%-4.59M-8.71%-19.58M19.60%-3.29M-57.53%-6.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More